Colgate-Palmolive grants 50,902 options to COO
COO Americas Shane Grant received new stock options and RSUs from Colgate-Palmolive, increasing his direct equity and option holdings.
Rhea-AI Filing Summary
COLGATE PALMOLIVE CO (CL) reported that Shane Grant, COO, Americas, received new equity awards on September 16, 2026. He was granted stock options for 50,902 shares of common stock at an exercise price of $87.02 per share, expiring September 16, 2036, vesting in one‑third increments beginning on the first anniversary of the grant date. He also received a restricted stock unit award covering 7,355 shares, which vests in three equal annual installments on the first, second and third anniversaries of the grant date. Following these awards, he directly holds 79,503 shares of common stock and 50,902 stock options; no Rule 10b5‑1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 58,257 shares
Grant/Award
2 txns
Insider
GRANT SHANE
Role
COO, Americas
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2, F3 | 50,902 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 7,355 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 50,902 contracts (Direct);
Common Stock — 79,503 shares (Direct)
Footnotes (3)
- F1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.
- F2. Stock option award granted under the issuer's incentive compensation plan.
- F3. Option becomes exercisable in one-third increments beginning on the first anniversary of the September 16, 2026 grant date.
Key Figures
Stock options granted: 50,902 options
Option exercise price: $87.02 per share
Option expiration date: September 16, 2036
+3 more
6 metrics
Stock options granted
50,902 options
Options on common stock granted to Shane Grant on September 16, 2026
Option exercise price
$87.02 per share
Exercise price of stock options granted September 16, 2026
Option expiration date
September 16, 2036
Expiration of stock options granted to Shane Grant
Restricted stock units granted
7,355 shares
RSU award to Shane Grant granted September 16, 2026
Common shares held after awards
79,503 shares
Direct common stock holdings of Shane Grant following the grants
Options held after awards
50,902 options
Stock options held by Shane Grant after the reported transactions
Key Terms
restricted stock unit, incentive compensation plan, stock option award
3 terms
restricted stock unit financial
"Restricted stock unit award granted under the issuer's incentive compensation plan."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
incentive compensation plan financial
"Restricted stock unit award granted under the issuer's incentive compensation plan."
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
stock option award financial
"Stock option award granted under the issuer's incentive compensation plan."
A stock option award is a grant that gives an employee the right to buy a company’s shares at a fixed price for a limited time, often becoming available gradually over a set schedule. Investors care because these awards align workers’ incentives with company performance, can increase employee loyalty, and may create future share dilution and compensation expense that affect earnings per share and shareholder value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Colgate-Palmolive (CL) grant to Shane Grant on September 16, 2026?
Shane Grant received stock options for 50,902 shares of Colgate-Palmolive common stock at an exercise price of $87.02, plus a restricted stock unit award for 7,355 shares, all granted under the company’s incentive compensation plan.
What is Shane Grant’s total Colgate-Palmolive (CL) common stock holding after these awards?
After the September 16, 2026 awards, Shane Grant directly holds 79,503 shares of Colgate-Palmolive common stock, in addition to 50,902 stock options linked to common shares.
How do Shane Grant’s new Colgate-Palmolive (CL) stock options vest and when do they expire?
The stock options for 50,902 shares become exercisable in one-third increments starting on the first anniversary of the September 16, 2026 grant date and expire on September 16, 2036.
What is the vesting schedule for Shane Grant’s new Colgate-Palmolive (CL) restricted stock units?
The restricted stock unit award for 7,355 shares vests in equal one-third installments on each of the first, second and third anniversaries of the September 16, 2026 grant date.
Were Shane Grant’s Colgate-Palmolive (CL) transactions made under a Rule 10b5-1 trading plan?
No. The filing indicates no Rule 10b5-1 trading plan for the transactions reported for Shane Grant on September 16, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
